Rachel Rebouché in the Media

MS Now July 17, 2026

News Blanche testimony has providers bracing for federal abortion crackdown

Professor Rachel Rebouché suggests that enforcing the Comstock Act would reverse the Trump administration’s earlier position and could threaten access to both medication and procedural abortions.

Law 360 July 17, 2026

Denying Emergency Abortion Care Is A Liability Oversight

Professor Rachel Rebouché co-authored an analysis arguing that hospitals may face greater legal liability for withholding emergency abortion care than for providing it under state abortion bans.

Spectrum News 1 June 26, 2026

Paxton’s support for IVF highlights broader divide among GOP

Professor Rachel Rebouché explains that an FDA safety study on a medication with track record of safety and efficacy like mifepristone is unprecedented, while emphasizing that widespread interstate conflicts over abortion access are just beginning.

The Conversation June 23, 2026

Medication abortion: Decisions from federal courts, the FDA or Trump’s Department of Justice could try to end access via telehealth

Professor Rachel Rebouché explains that decisions by the federal courts, the FDA, or the Department of Justice could significantly  restrict access to medication abortion through Telehealth.

the Los Angles Times June 23, 2026

The looming threats to abortion access in 2026

Professor Rachel Rebouché argues that medication abortion remains vulnerable despite recent court decisions preserving access, explaining for legal challenges and state shield laws could significantly restrict access.  

The Atlantic June 14, 2026

So Much for Leaving Abortion Up to the States

Professor Rachel Rebouché weighs in on a discussion about the use of abortion pills in Louisiana, noting that policing access to these drugs would be very expensive and intrusive.

KPRC June 8, 2026

Houston-area midwife reindicted on 22 counts, including financial harm allegations

Professor Rachel Rebouché discusses the indictment of a Houston area midwife facing abortion-related charges, explaining how the case could shape the future enforcement of Texas abortion laws.

The Texas Tribune May 7, 2026

What to know about the federal rule that Texans have used to mail in abortion pills

Professor Rachel Rebouché calls the Supreme Court's temporary block unsurprising and likely intended to prevent disruption to medical care, noting that abruptly changing the legal status of a widely used drug creates significant confusion.

Wisconsin Public Radio May 5, 2026

Here’s how recent legal decisions around abortion pill access could impact Wisconsinites

Professor Rachel Rebouché notes that the parties in a Louisiana case regarding mailing of the abortion pill mifepristone must quickly file their responses, after which time the Supreme Court will consider whether the 5th U.S. Circuit Court of Appeals was right or wrong imposing restrictions on distribution of the medication.

Texas Standard May 5, 2026

Supreme Court order keeps abortion pill access in flux

As a guest on Texas Standard, Professor Rachel Rebouché walks through recent legal proceedings and rulings regarding a fast-moving fight over abortion medication following last week's 5th Circuit ruling, which halted mail-order prescriptions of mifepristone.

Bloomberg Law May 4, 2026

Bids to Expand Abortion Access in States Target Provider Limits

Professor Rachel Rebouché suggests that suits challenging physician-only abortion laws could succeed in states that have other protections for reproductive rights, so expanding who can perform abortions is viable where state-level constitutional or privacy protections already exist.

The Nation May 2, 2026

The Fifth Circuit Seeks to Unilaterally Reimpose an Outdated Abortion Pill Protocol

Professor Rachel Rebouché argues that the legally dubious ruling issued by the Fifth Circuit reimposing an outdated in-person pickup requirement for Mifepristone that effectively banned telehealth medication abortion nationwide ignores overwhelming safety evidence, contradicts other court decisions, and will fail to stop abortion access regardless of what the Supreme Court ultimately decides.